Artiklar

Atopic dermatitis (AD) is a chronic inflammatory skin condition that can significantly impact patients' quality of life. Dupixent (dupilumab) has emerged as a treatment for moderate-to-severe AD. This article summarizes the findings of a 5-year open-label extension study (Beck et al, 2024), providing insights into the long-term efficacy and safety profile of Dupixent for dermatologists managing patients with persistent AD.

Curious about the characteristics of pre-symptomatic- and stage 3 Type 1 Diabetes? Interested in learning about the potential benefits of screening for autoimmune Type 1 Diabetes?

This short film gives you an overview of recent developments in diagnosis of Type 1 Diabetes, showcasing how early detection efforts can benefit those who need it the most.

Felicita Andreotti, Italy; Christiaan J M Vrints, Belgium

Att förstå typ 2-inflammation^* kan hjälpa till att belysa varför vissa patienter fortsätter att få exacerbationer. Titta på denna video för att lära dig hur.¹

Systematic early detection of autoimmune Type 1 Diabetes might be a new way to avoid acute and chronic complications of the condition.^1-5 This new approach may play a role as a revolutionary shift, helping to shape the future of Type 1 Diabetes management.²

This infographic summarizes survey data^* about the impact that families across the Nordic countries have felt when being diagnosed with autoimmune Type 1 Diabetes (T1D).

Start to think differently about Type 1 Diabetes by considering the pre-symptomatic stages of the condition and how it affects people of all ages and their families.